Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason Cell Stem Cell

Slides:

Advertisements

Similar presentations

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.

Advertisements

What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell

Distinct Self-Renewal and Differentiation Phases in the Niche of Infrequently Dividing Hair Follicle Stem Cells Ying V. Zhang, Janice Cheong, Nichita Ciapurin,

Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni

Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair Francesco S. Loffredo, Matthew L. Steinhauser,

Distribution of Human Embryonic Stem Cell Lines: Who, When, and Where Jennifer B. McCormick, Jason Owen-Smith, Christopher Thomas Scott Cell Stem Cell.

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem

Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells David J. Wong, Helen Liu, Todd W. Ridky, David Cassarino, Eran Segal, Howard.

IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.

Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.

Fate Restriction and Multipotency in Retinal Stem Cells Lázaro Centanin, Burkhard Hoeckendorf, Joachim Wittbrodt Cell Stem Cell Volume 9, Issue 6, Pages.

Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle Isabel Beerman, Jun Seita, Matthew A.

Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.

Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.

Quantitative Single-Cell Approaches to Stem Cell Research Martin Etzrodt, Max Endele, Timm Schroeder Cell Stem Cell Volume 15, Issue 5, Pages (November.

Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey

Chemotherapy and Cancer Stem Cells

Cutaneous Cancer Stem Cells: β-Catenin Strikes Again

Cancer: Inappropriate Expression of Stem Cell Programs?

Volume 1, Issue 5, Pages (November 2007)

Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey

Scott N. Freeman, Kathryn A. Burke, Menfo A. Imoisili, Timothy R. Coté

Leigh Turner, Paul Knoepfler Cell Stem Cell

Volume 1, Issue 1, Pages (June 2007)

Human Induced Pluripotent Stem Cells: Now Open to Discovery

Cell Cycle Rules Pluripotency

Grounded: Transcriptional Pausing in Naive mESCs

A Path to Insulin Independence: “The End of the Beginning”

Volume 12, Issue 6, Pages (June 2013)

Volume 9, Issue 2, Pages (August 2011)

The Evolution of the Algorithms for Collective Behavior

Gerry P. Crossan, Juan I. Garaycoechea, Ketan J. Patel Cell Stem Cell

Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs

New Japanese Initiatives on Stem Cell Therapies

Public Private Partnerships: A Marriage of Necessity

MSCs, Macrophages, and Cancer: A Dangerous Ménage-à-Trois

Volume 21, Issue 6, Pages (December 2017)

Natalia J. Martinez, Richard I. Gregory Cell Stem Cell

Transplantable Liver Organoids Made from Only Three Ingredients

Regulating Cancer Stem Cells the miR Way

Wing Y. Chang, William L. Stanford Cell Stem Cell

Guillaume Richard-Carpentier, Guy Sauvageau Cell Stem Cell

Volume 10, Issue 5, Pages (May 2012)

Stem Cell Therapies in Clinical Trials: Progress and Challenges

Wenlian Qiao, Peter W. Zandstra Cell Stem Cell

Human Induced Pluripotent Stem Cells: Now Open to Discovery

Cutaneous Cancer Stem Cells: β-Catenin Strikes Again

CHD7 in Charge of Neurogenesis

Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs

Putting Two Heads Together to Build a Better Brain

Volume 18, Issue 2, Pages (February 2016)

Loukia Yiangou, Alexander D.B. Ross, Kim Jee Goh, Ludovic Vallier

Targeting β-catenin in CML: Leukemia Stem Cells Beware!

Volume 11, Issue 6, Pages (December 2012)

Order from Chaos: Single Cell Reprogramming in Two Phases

Transplantable Liver Organoids Made from Only Three Ingredients

The Promise and Perils of Stem Cell Therapeutics

Powering Reprogramming with Vitamin C

Regulating Autologous Adult Stem Cells: The FDA Steps Up

Timothy R. Donahue, David W. Dawson Cell Stem Cell

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

The Side Story of Stem-like Glioma Cells

Volume 22, Issue 4, Pages (April 2018)

Regulating Autologous Adult Stem Cells: The FDA Steps Up

Chapter 29 - Stem Cells and Generation of New Cells in the

Jeremy Sugarman, Andrew Siegel Cell Stem Cell

Volume 11, Issue 6, Pages (December 2012)

Targeting Protein Stability with a Small Molecule

Presentation transcript:

Evolving Industry Partnerships and Investments in Cell and Gene Therapies Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason Cell Stem Cell Volume 22, Issue 5, Pages 623-626 (May 2018) DOI: 10.1016/j.stem.2018.03.004 Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 1 The Majority of the Public Transactions/Investments Made by Large Pharma Companies for Therapeutics in the Cell and Gene Therapy Space between 2010 and 2016 (A) Summary of the different transaction types, determined by the nature of the deal. (B) Summary of the transactions by year by therapeutic area, determined by evaluating the targeted indications and placing them into relevant therapeutic areas. (C) Summary of the transactions by year by technology type. (D) Top entities that have performed the most transactions over the period. Cell Stem Cell 2018 22, 623-626DOI: (10.1016/j.stem.2018.03.004) Copyright © 2018 Elsevier Inc. Terms and Conditions